                         SEQUENCE LISTING

<110>  Yeda Research And Development Co. Ltd.
       Toister, Einat
       Shachar, Idit
 
<120>  COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION

<130>  53611

<150>  US 61/468,109
<151>  2011-03-28

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  253
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Gly Glu Phe Asn Glu Lys Lys Thr Thr Cys Gly Thr Val Cys Leu 
1               5                   10                  15      


Lys Tyr Leu Leu Phe Thr Tyr Asn Cys Cys Phe Trp Leu Ala Gly Leu 
            20                  25                  30          


Ala Val Met Ala Val Gly Ile Trp Thr Leu Ala Leu Lys Ser Asp Tyr 
        35                  40                  45              


Ile Ser Leu Leu Ala Ser Gly Thr Tyr Leu Ala Thr Ala Tyr Ile Leu 
    50                  55                  60                  


Val Val Ala Gly Thr Val Val Met Val Thr Gly Val Leu Gly Cys Cys 
65                  70                  75                  80  


Ala Thr Phe Lys Glu Arg Arg Asn Leu Leu Arg Leu Tyr Phe Ile Leu 
                85                  90                  95      


Leu Leu Ile Ile Phe Leu Leu Glu Ile Ile Ala Gly Ile Leu Ala Tyr 
            100                 105                 110         


Ala Tyr Tyr Gln Gln Leu Asn Thr Glu Leu Lys Glu Asn Leu Lys Asp 
        115                 120                 125             


Thr Met Thr Lys Arg Tyr His Gln Pro Gly His Glu Ala Val Thr Ser 
    130                 135                 140                 


Ala Val Asp Gln Leu Gln Gln Glu Phe His Cys Cys Gly Ser Asn Asn 
145                 150                 155                 160 


Ser Gln Asp Trp Arg Asp Ser Glu Trp Ile Arg Ser Gln Glu Ala Gly 
                165                 170                 175     


Gly Arg Val Val Pro Asp Ser Cys Cys Lys Thr Val Val Ala Leu Cys 
            180                 185                 190         


Gly Gln Arg Asp His Ala Ser Asn Ile Tyr Lys Val Glu Gly Gly Cys 
        195                 200                 205             


Ile Thr Lys Leu Glu Thr Phe Ile Gln Glu His Leu Arg Val Ile Gly 
    210                 215                 220                 


Ala Val Gly Ile Gly Ile Ala Cys Val Gln Val Phe Gly Met Ile Phe 
225                 230                 235                 240 


Thr Cys Cys Leu Tyr Arg Ser Leu Lys Leu Glu His Tyr 
                245                 250             


<210>  2
<211>  63
<212>  PRT
<213>  Artificial sequence

<220>
<223>  CD151-ECD synthetic peptide

<400>  2

Leu Asn Thr Glu Leu Lys Glu Asn Leu Lys Asp Thr Met Thr Lys Arg 
1               5                   10                  15      


Tyr His Gln Pro Gly His Glu Ala Val Thr Ser Ala Val Asp Gln Leu 
            20                  25                  30          


Gln Gln Glu Phe His Cys Cys Gly Ser Asn Asn Ser Gln Asp Trp Arg 
        35                  40                  45              


Asp Ser Glu Trp Ile Arg Ser Gln Glu Ala Gly Gly Arg Val Val 
    50                  55                  60              


<210>  3
<211>  189
<212>  DNA
<213>  Artificial sequence

<220>
<223>  CD151-ECD coding sequence

<400>  3
ctgaacacgg agctcaagga gaacctgaag gacaccatga ccaagcgcta ccaccagccg       60

ggccatgagg ctgtgaccag cgctgtggac cagctgcagc aggagttcca ctgctgtggc      120

agcaacaact cacaggactg gcgagacagt gagtggatcc gctcacagga ggccggtggc      180

cgtgtggtc                                                              189


<210>  4
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Control peptide

<400>  4

Lys Gln Ile Ile Asn Met Trp Gln Glu Val Gly Lys Ala Met Tyr Ala 
1               5                   10                  15      


Arg Pro Asn Asn Asn Thr Arg Lys Ser Ile His Ile Gly Pro Gly Arg 
            20                  25                  30          


Ala Phe Tyr Thr Thr Gly Glu Ile 
        35                  40  


<210>  5
<211>  63
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Control scrambled peptide

<400>  5

Lys Gly Asp Ala Arg Val Asn Arg Asn Val Ala Glu Gln Gln Glu Ser 
1               5                   10                  15      


Leu Ser Trp Lys Thr Leu Trp Leu Asp Gly Thr Leu Asp Ser Glu Glu 
            20                  25                  30          


Met Thr Asn Ala Cys Ser Pro Gln Glu Asp Ile Thr Val Arg His Asn 
        35                  40                  45              


Arg Gln Lys Val Tyr Gln Phe Gly His Glu Cys Ser His Gly Gln 
    50                  55                  60              


